Pathology

Overview

Established in 1975, the Pathology Lab has grown to match the requirements of Oncology diagnosis and speciality care. The department is well supported by updated automation and well-trained, dedicated, experienced technical staff to carry out the special investigations required for oncology.

The Pathology department hosts an in-house automated IHC analyser, a Serum tumour marker (CLIA) analyser of the best possible configuration, which is available at select centres only. The department is well equipped to handle Biopsy processing for delicate core biopsies to robust oncosurgical specimens, with thorough dissection for detailed reporting as per CAP guidelines, pTNM staging, and IHC.

Breast cancer cases undergo comprehensive workup with Trucut biopsy followed by in-house hormonal assessment, Her2neu, and Ki67 markers, all within a week to be discussed at the Tumour Board for further treatment protocol.

Hematological malignancies and under workup cases are taken care of by bone marrow examination including Trephine biopsy, cytochemistry (MPO), and processed for flowcytometry and cytogenetics workup in conjunction with one of the best oncocare diagnostics within a stipulated time frame. The Pathology Lab also facilitates Daycare Chemotherapy services by providing urgent haematological, serological, and Biochemical investigations within a short time frame.

Feasibility for submission of cases to be reviewed histopathologically
and guidance on further therapeutic decisions are offered by Histopathologists, both for in-house and outside cases.

All the above services are enrolled for quality assurance (EQAS) with nationally accredited organisations like ISHTM-AIIMS (Delhi), CMC Vellore and National Cancer Grid-NCG (TMH Mumbai).

What we offer

Complete haematological & Biochemical tests profile including Hormone assay

Serum Methotrexate assay results available within a short period
Fine needle aspiration cytology (Direct & Imaging guidance) for all types of lesions
Comprehensive body fluid analysis including biochemical, cytological and cell block preparation, facilitated by IHC (in feasible cases)
PAP smear cytology and HPV screening facility
Bone marrow aspiration and trephine biopsy (admission/outdoor basis) with flowcytometry*, cytogenetics* and IHC assessment
Cytochemistry – MPO, PAS

Small & large tissue excision biopsy processing for cancerous and noncancerous specimens
Core and needle biopsy processing and reporting within 4 days
Slide and block review with second opinion including special tests confirmation
Immunohistochemistry
Pathologist consultation available
Molecular Testing in-house and real-time PCR-based EGFR panel, HRHPV on FFPE, BCR-ABL1 IS% on peripheral and bone marrow samples

Quality assurance standards

NABL (ISO 15189:2012) Accreditation in Haematology, Biochemistry, and

EQAS certifications

Unique features

Inhouse IHC facilities
Comprehensive cancer biopsy processing and reporting of the case as per NCCN guidelines
In-house serum tumour markers and hormone assays available on a wide range
Tumour board assessment with a complete review of reports and case discussion for treatment planning
Two dedicated, full-time Consultants and a qualified Technical team to perform special tests as indicated above

Feasibility

Contact

Walk in for lab tests (Monday – Saturday, blood sample collection upto 5pm, Biopsy submission up to 6pm)

* indicates outsourced
** Immunohistochemistry for ER PR Her2neu Ki67 index Inhouse. Other markers as customised panels outsourced at competitive rates from reliable, internationally accredited agencies

#CA125, CEA, CA19.9, CA15.3, AFP, LDH, BHCG, PSA,

LH, FSH, T3, T4, TSH, VitB12, Folate, VITD3